Mandate

Vinge advises Allianz X

December 21, 2017

Vinge advises Allianz X, the digital investment unit of the Allianz Group, in its US$96.6 million investment in BIMA.

This round positions BIMA to cement its leadership in micro-insurance and accelerate the delivery of affordable insurance to underserved populations.

Vinge´s team consisted of partner Fredrik Sonander and associate Petronella Hallberg.

Related

Vinge advises HealthCap in conjunction with an investment in Neobiomics

HealthCap is investing in Neobiomics AB, which develops products in the neonatal field. Neobiomics’ flagship product, Proprems, is a probiotic dietary supplement developed for preterm infants.
May 22, 2026

Vinge advises Sveafastigheter in its merger with KlaraBo

Vinge advises Sveafastigheter AB (publ) in its merger with KlaraBo Sverige AB.
May 22, 2026

Vinge advises Lagercrantz Group in conjunction with the acquisition of Stalon

Lagercrantz Group Aktiebolag has acquired 88 per cent of the shares in Stalon AB, a Swedish manufacturer of silencers for hunting firearms. The company is based in Stalon, which is located outside Vilhelmina, where the company conducts development and production in its own facilities.
May 21, 2026